US23312M1062 - DALS (XNAS)

DA32 Life Science Tech Acquisition Corp. Acción

Sin cotización

Performance

Day	Week	Month	3 Months	6 Months	1 Year	5 Years
-	-	-	-	0,00 %	0,00 %	4,88 %

Company Profile for DA32 Life Science Tech Acquisition Corp. Share

DA32 Life Science Tech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to identify business combination targets in the biotechnology and life science infrastructure sectors. DA32 Life Science Tech Acquisition Corp. was incorporated in 2021 and is based in New York, New York.

Company Data for DA32 Life Science Tech Acquisition Corp. Share

Name DA32 Life Science Tech Acquisition Corp.

Company DA32 Life Science Tech Acquisition Corp.

Symbol DALS

Primary Exchange

NASDAQ

ISIN US23312M1062

Asset Class Share

Sector Financial Services

Industry Shell Companies

CEO Dr. Steven Kafka Ph.D.

Market Capitalization 264 Mio

Country United States of America

Currency USD

Employees -

Address 345 Park Avenue South, 10010 New York

IPO Date 2021-07-28

Ticker Symbols

Name	Symbol
NASDAQ	DALS

More Shares

Investors who DA32 Life Science Tech Acquisition Corp. hold also have the following shares in their portfolio:

DZ BANK IS.A2679 Bond

FREEL.THERAP.H.SP.ADS/15 Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Jobs Community Feedback Changelog